Sunscreen TEA Advocates Want Help Clearing FDA’s ‘High Bar’ For GRASE
This article was originally published in The Rose Sheet
Executive Summary
FDA explained its “high bar” for GRASE designations awarded to ingredients in sunscreen TEAs during a public meeting on implementation of the Sunscreen Innovation Act. Industry and advocacy groups are concerned that impediments to meeting OTC monograph safety standards will squelch sunscreen ingredient innovation.
You may also be interested in...
FDA 'May Hold Private Meetings' Offer Eases Sunscreen Monograph Tension
Proposed final sunscreen monograph published in February provided more clarity for TEA sponsors to engage with agency, but May publication of final guidance on MUsT for topically applied ingredients for OTC drug monograph could motivate TEA sponsors for sunscreen and other topical active ingredients to push their proposals forward.
All Roads For OTC Policy Improvements Lead To User Fees, FDA Suggests
In an update on discussions with industry about potential user fees to support FDA's OTC monograph program, CDER officials say "industry and public would suffer" absent new fees.
Fourth Time’s A Charm? President’s FY 2016 Budget Includes Cosmetic Fees
Continuing what has become a familiar refrain, the Obama administration’s fiscal 2016 budget request for FDA includes cosmetics user fees, marking the fourth consecutive year that such a system has been proposed. Legislation would need to be introduced – and passed – in order to establish cosmetics user fees.